Use of single point mutations in domain I of β2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies

GM Iverson, S Reddel, EJ Victoria… - The Journal of …, 2002 - journals.aai.org
Autoantibodies against β 2-glycoprotein I (β 2 GPI) appear to be a critical feature of the
antiphospholipid syndrome (APS). As determined using domain deletion mutants, human …
被引用次数：181 相关文章
[PDF] researchgate.net

[PDF][PDF] Use of Single Point Mutations in Domain I of ß2-Glycoprotein I to Determine Fine Antigenic Specificity of Antiphospholipid Autoantibodies

GM Iverson, S Reddel, EJ Victoria, KA Cockerill… - 2002 - researchgate.net
Autoantibodies against ß2-glycoprotein I (ß2GPI) appear to be a critical feature of the
antiphospholipid syndrome (APS). As determined using domain deletion mutants, human …

Use of Single Point Mutations in Domain I of β2-Glycoprotein I to Determine Fine Antigenic Specificity of Antiphospholipid Autoantibodies

GM Iverson, S Reddel, EJ Victoria… - The Journal of …, 2002 - journals.aai.org
Autoantibodies against β2-glycoprotein I (β2GPI) appear to be a critical feature of the
antiphospholipid syndrome (APS). As determined using domain deletion mutants, human …

Use of single point mutations in domain I of beta 2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies

GM Iverson, S Reddel, EJ Victoria… - Journal of …, 2002 - pubmed.ncbi.nlm.nih.gov
Autoantibodies against beta (2)-glycoprotein I (beta (2) GPI) appear to be a critical feature of
the antiphospholipid syndrome (APS). As determined using domain deletion mutants …
[PDF] salilab.org

[PDF][PDF] Use of Single Point Mutations in Domain I of ß2-Glycoprotein I to Determine Fine Antigenic Specificity of Antiphospholipid Autoantibodies

GM Iverson, S Reddel, EJ Victoria, KA Cockerill… - 2002 - salilab.org
Autoantibodies against ß2-glycoprotein I (ß2GPI) appear to be a critical feature of the
antiphospholipid syndrome (APS). As determined using domain deletion mutants, human …
[PDF] salilab.org

[PDF][PDF] Use of Single Point Mutations in Domain I of ß2-Glycoprotein I to Determine Fine Antigenic Specificity of Antiphospholipid Autoantibodies

GM Iverson, S Reddel, EJ Victoria, KA Cockerill… - 2002 - salilab.org
Autoantibodies against ß2-glycoprotein I (ß2GPI) appear to be a critical feature of the
antiphospholipid syndrome (APS). As determined using domain deletion mutants, human …

Use of single point mutations in domain I of beta 2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies.

GM Iverson, S Reddel, EJ Victoria… - … (Baltimore, Md.: 1950 …, 2002 - europepmc.org
Autoantibodies against beta (2)-glycoprotein I (beta (2) GPI) appear to be a critical feature of
the antiphospholipid syndrome (APS). As determined using domain deletion mutants …
[PDF] psu.edu

[PDF][PDF] Use of Single Point Mutations in Domain I of ß2-Glycoprotein I to Determine Fine Antigenic Specificity of Antiphospholipid Autoantibodies

GM Iverson, S Reddel, EJ Victoria, KA Cockerill… - 2002 - Citeseer
Autoantibodies against ß2-glycoprotein I (ß2GPI) appear to be a critical feature of the
antiphospholipid syndrome (APS). As determined using domain deletion mutants, human …

Use of Single Point Mutations in Domain I of β2-Glycoprotein I to Determine Fine Antigenic Specificity of Antiphospholipid Autoantibodies

GM Iverson, S Reddel, EJ Victoria… - The Journal of …, 2002 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Autoantibodies against β2-glycoprotein I
(β2GPI) appear to be a critical feature of the antiphospholipid syndrome (APS). As …

[引用][C] Use of single point mutations in domain I of beta 2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies

I GM - J Immunol, 2002 - cir.nii.ac.jp
Use of single point mutations in domain I of beta 2-glycoprotein I to determine fine antigenic
specificity of antiphospholipid autoantibodies | CiNii Research CiNii 国立情報学研究所 学術 …